News
Monday, May 5th, 2014
Clinical Diabetes: April 2014 The authors studied patients with diabetes and complaints of dizziness to determine whether peripheral neuropathy or inner ear dysfunction was more likely to disturb balance. Quantitative testing showed that the majority failed to maintain balance in vestibular-related conditions and had normal equilibrium scores in conditions relying on somatosensory input. Vestibular dysfunction should […]
Minority Diabetes Reports
Monday, May 5th, 2014
Diabetes Care: April 4, 2014 OBJECTIVE We compared South Asians with four other race/ethnic groups in the U.S. to determine whether sociodemographic, lifestyle, or metabolic factors could explain the higher diabetes prevalence, and whether insulin resistance and β-cell dysfunction occurred at younger ages and/or lower adiposity levels compared with other groups. RESEARCH DESIGN AND METHODS Cross-sectional analysis of […]
Minority Diabetes Reports
Monday, May 5th, 2014
The Diabetes Educator: April 2, 2014 Purpose The purposes of this review were to identify the needs and concerns of family caregivers of persons with type 2 diabetes and to develop recommendations for future research on family caregivers of American Indians with type 2 diabetes. Searching the Cumulative Index to Nursing and Allied Health, Ovid, and PubMed, […]
Clinical Trial News
Monday, May 5th, 2014
The Lancet Diabetes & Endocrinology: April 4, 2014 Background When patients with type 2 diabetes start their first injectable therapy, clinicians can choose between glucagon-like peptide-1 (GLP-1) receptor agonists and basal insulins. In DURATION-3, exenatide once weekly was compared with insulin glargine (henceforth, glargine) as first injectable therapy. Here, we report the results of the final […]
Clinical Trial News
Monday, May 5th, 2014
Diabetes Care: April 4, 2014 OBJECTIVE Plasma adiponectin levels are reduced in type 2 diabetes mellitus (T2DM) and other insulin-resistant states. We examined whether plasma adiponectin levels at baseline and after pioglitazone treatment in impaired glucose tolerance (IGT) subjects were associated with improved insulin sensitivity (SI) and glucose tolerance status. RESEARCH DESIGN AND METHODS A total of 602 […]
Clinical Trial News
Monday, May 5th, 2014
Am J Clin Nutr: June 2014 Background: The results of human clinical trials investigating the effects of resveratrol on glucose control and insulin sensitivity are inconsistent. Objective: We aimed to quantitatively evaluate the effects of resveratrol on glucose control and insulin sensitivity. Design: We performed a strategic literature search of PubMed, Embase, MEDLINE, and the Cochrane Library (updated […]
Clinical Trial News
Monday, May 5th, 2014
Diabetes: April 2, 2014 The potential influence of gastric emptying on the ‘incretin effect’, mediated by glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), is unknown. The objectives of this study were to determine the effects of intraduodenal glucose infusions at 2 (ID2) and 4 (ID4) kcal/min (equating to two rates of gastric emptying within the […]
Clinical Trial News
Monday, May 5th, 2014
The Lancet Diabetes & Endocrinology: March 5, 2014 Background Reduction of dietary sodium intake or diuretic treatment increases renin-angiotensin-aldosterone system (RAAS) blockade efficacy in non-diabetic nephropathy. We aimed to investigate the effect of sodium restriction and the diuretic hydrochlorothiazide, separately and in combination, added to RAAS blockade on residual albuminuria in patients with type 2 diabetic […]
News
Monday, May 5th, 2014
Diabetes Care: April 4, 2014 OBJECTIVE By correlating known diabetes duration with the prevalence of retinopathy, more than 10 years have been estimated to lapse between the onset and diagnosis of type 2 diabetes. Such calculations, however, assumed a linear model, included stages of retinopathy not specific to diabetes, and allowed 5 years for retinopathy to occur […]
News
Monday, May 5th, 2014
The Diabetes Educator: April 2, 2014 Purpose This article provides an overview of the clinical and economic issues associated with hypoglycemia in patients with type 1 and type 2 diabetes mellitus. Current research regarding hypoglycemia is comprehensively reviewed, with special emphasis on nocturnal hypoglycemia, as almost 50% of all severe hypoglycemic episodes occur at nighttime during sleep. […]
